Gabriella Hobbs

26PUBLICATIONS
192CO-AUTHORS
Haematological tumoursCardiology (incl. cardiovascular diseases)Respiratory diseasesHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 20, 2026
Impact of cytoreductive therapy in myeloproliferative neoplasm-associated splanchnic vein thrombosis.

|Mar 04, 2026
Low serum cholesterol is a biomarker of advanced disease and poor outcomes in myeloproliferative neoplasms.

Orly Leiva, Steven Soo, Olivia C Liu

|Jan 07, 2026
Impact of statin use on cardiovascular and hematologic outcomes among patients with myeloproliferative neoplasms.

Orly Leiva, Steven Soo, Olivia C Liu

|Jul 29, 2025
HiJAKing the hematopoietic system: a low-frequency JAK2V617F clone drives myeloproliferative neoplasm pathology.

Dennis M Bonal, Alissa Oakes, Anna Chorzalska

|Jun 10, 2025
Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms.

Orly Leiva, Steven Soo, Nathaniel R Smilowitz

|Mar 22, 2025
Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: eligibility, best practices, and improving transplant outcomes.

Sarah A Wall, Roni Tamari, Zachariah DeFilipp

Pageof 5

Frequent Collaborators

7 joint publications

Joan How

6 joint publications

Michelle Hyunju Lee

4 joint publications

Anand Patel

4 joint publications

John O Mascarenhas